These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 30587856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice.
    Bhuiyan AS, Rafiq K, Kobara H, Masaki T, Nakano D, Nishiyama A.
    Hypertens Res; 2019 Jun; 42(6):892-902. PubMed ID: 30664703
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats.
    Rahman A, Sawano T, Sen A, Hossain A, Jahan N, Kobara H, Masaki T, Kosaka S, Kitada K, Nakano D, Imamura T, Ohsaki H, Nishiyama A.
    Int J Mol Sci; 2021 Feb 19; 22(4):. PubMed ID: 33669786
    [Abstract] [Full Text] [Related]

  • 4. Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker.
    Arai K, Morikawa Y, Ubukata N, Sugimoto K.
    Hypertens Res; 2020 Nov 19; 43(11):1204-1213. PubMed ID: 32616846
    [Abstract] [Full Text] [Related]

  • 5. [Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats].
    Wu HY, Liang YX, Bai Q, Zhuang Z, A LT, Zheng DX, Wang Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Feb 18; 47(1):149-54. PubMed ID: 25686347
    [Abstract] [Full Text] [Related]

  • 6. Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats.
    Hattori M, Rahman A, Kidoguchi S, Jahan N, Fujisawa Y, Morisawa N, Ohsaki H, Kobara H, Masaki T, Hossain A, Steeve A, Nishiyama A.
    Int J Mol Sci; 2022 Aug 10; 23(16):. PubMed ID: 36012182
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of Piezo2 in the mesangial, renin, and perivascular mesenchymal cells of the kidney of Dahl salt-sensitive hypertensive rats and its reversal by esaxerenone.
    Ochiai K, Mochida Y, Nagase T, Fukuhara H, Yamaguchi Y, Nagase M.
    Hypertens Res; 2023 May 10; 46(5):1234-1246. PubMed ID: 36810623
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of intrarenal renin-agiotensin system contributes to renal damage in high-salt induced hypertension rats.
    Wu H, Liang Y, Zheng Y, Bai Q, Zhuang Z, A L, Zheng D, Wang Y.
    Kidney Blood Press Res; 2014 May 10; 39(6):526-35. PubMed ID: 25531334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.
    Rands VF, Seth DM, Kobori H, Prieto MC.
    Gend Med; 2012 Aug 10; 9(4):207-18. PubMed ID: 22795463
    [Abstract] [Full Text] [Related]

  • 11. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
    Rafiq K, Nishiyama A, Konishi Y, Morikawa T, Kitabayashi C, Kohno M, Masaki T, Mori H, Kobori H, Imanishi M.
    PLoS One; 2014 Aug 10; 9(9):e107853. PubMed ID: 25233358
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
    Zhu A, Yoneda T, Demura M, Karashima S, Usukura M, Yamagishi M, Takeda Y.
    J Hypertens; 2009 Apr 10; 27(4):800-5. PubMed ID: 19516179
    [Abstract] [Full Text] [Related]

  • 14. Effects of Exercise Training on the Renin-Angiotensin System in the Kidneys of Dahl Salt-Sensitive Rats.
    Sakuyama A, Ogawa Y, Xu L, Komatsu M, Miura T, Namai-Takahashi A, Kohzuki M, Ito O.
    Med Sci Sports Exerc; 2022 Jul 01; 54(7):1105-1113. PubMed ID: 35220367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 01; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension.
    Lara LS, McCormack M, Semprum-Prieto LC, Shenouda S, Majid DS, Kobori H, Navar LG, Prieto MC.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F85-94. PubMed ID: 21900456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacological profile, clinical efficacy, and safety of esaxerenone (Minnebro® tablets 1.25 mg, 2.5 mg, 5 mg)].
    Yamakawa S, Homma T, Yamada M, Igawa Y, Yoshimura M.
    Nihon Yakurigaku Zasshi; 2020 Jan 01; 155(5):340-350. PubMed ID: 32879177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.